Sharing our perspective

Sharing perspectives leads to greater understanding and fuels innovation. The ​Optum Insights ​blog is where we share our perspective and challenge preconceptions to clear a new path forward.


  • Update to medical device shortages manufactured in Puerto Rico

    by
    • Optum Workers' Comp
    | Dec 21, 2017
    Tag Icon
    FDA
    In October, we reported in our blog about the number of shortages of medical devices and drug products manufactured by facilities in Puerto Rico following the devastation and power outages from Hurricanes Irma and Maria. Recently, the U.S. Food and Drug Administration (FDA) provided an update on the situation. Though some power has been restored to the island and a handful of facilities have been able to stabilize production, many facilities continue to require the use of generators for power and have been unable to return to baseline production levels.


  • FDA promotes the development of generic versions of abuse-deterrent opioid analgesics

    by
    • Optum Workers' Comp
    | Dec 19, 2017
    Tag Icon
    Generics, Opioids, FDA
    The U.S. Food and Drug Administration (FDA) has approved ten opioid analgesics with abuse-deterrent formulations (ADFs) to date. Opioid analgesics with ADFs are designed to make certain types of abuse, such as crushing a tablet to snort or dissolving a capsule to inject, more difficult or less rewarding. However, according to the Institute for Clinical and Economic Review (ICER) report “Abuse-Deterrent Opioids: Effectiveness and Value” published in August, only one opioid, OxyContin® (oxycodone extended-release), demonstrated sufficient evidence to suggest a reduced risk of abuse compared to non-ADF opioid analgesics.


  • Optum awarded NCQA 3-Year Case Management Accreditation

    by
    • Optum Workers' Comp
    | Dec 15, 2017
    Tag Icon
    Workers' Compensation
    We’re proud to announce that the Optum Case Management program received certification from the National Committee for Quality Assurance (NCQA). Recognized for quality, the NCQA reviewed our policies, procedures and data reporting and awarded us the highest level of accreditation—a 3 year accreditation—for our comprehensive case management program.


  • Final approval of the California workers’ compensation MTUS drug formulary

    by
    • Optum Workers' Comp
    | Dec 13, 2017
    Tag Icon
    formulary
    The California Office of Administrative Law has approved the final MTUS Drug Formulary regulations submitted by the Division of Workers’ Compensation (DWC) fully adopting a workers’ compensation drug formulary. The formulary and related rules will go into effect January 1, 2018.






Subscribe

Stay informed by signing up to receive newsletters, alerts, insights and videos.
You can customize your content preferences after you subscribe.